CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,087 | +23308.7% | 15,700 | +27935.7% | 0.00% | – |
| Q3 2018 | $1,000 | -97.1% | 56 | -97.9% | 0.00% | – |
| Q2 2018 | $35,000 | +105.9% | 2,638 | +100.8% | 0.00% | – |
| Q1 2018 | $17,000 | +21.4% | 1,314 | -12.4% | 0.00% | – |
| Q4 2017 | $14,000 | +16.7% | 1,500 | 0.0% | 0.00% | – |
| Q3 2017 | $12,000 | +300.0% | 1,500 | -15.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 1,764 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -76.9% | 1,764 | -76.1% | 0.00% | – |
| Q2 2016 | $13,000 | -61.8% | 7,374 | -70.8% | 0.00% | – |
| Q1 2016 | $34,000 | -20.9% | 25,274 | 0.0% | 0.00% | – |
| Q4 2015 | $43,000 | -4.4% | 25,274 | +8.0% | 0.00% | – |
| Q3 2015 | $45,000 | -28.6% | 23,400 | 0.0% | 0.00% | – |
| Q2 2015 | $63,000 | – | 23,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |